Journal of Hepatology
Volume 51, Issue 5 , Pages 839-841 , November 2009

Hepatitis C after simultaneous liver–kidney transplantation

  • Andreas Cerny

      Affiliations

    • Corresponding Author InformationTel.: +41 91 960 85 03; fax: +41 91 960 87 18.

References 

  1. Van Wagner LB, Baker T, Ahya SN, Norvell JP, Wang E, Levitsky J. Outcomes of patients with hepatitis C undergoing simultaneous liver–kidney transplantation. J Hepatol. 2009;51:874–880
  2. Chan TM, Lok AS, Cheng IK, Ng IO. Chronic hepatitis C after renal transplantation. Treatment with alpha-interferon. Transplantation. 1993;56:1095–1098
  3. Baid S, Tolkoff-Rubin N, Saidman S, Chung R, Williams WW, Auchincloss H, et al. Acute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy. Am J Transplant. 2003;3:74–78
  4. Schmitz V, Kiessling A, Bahra M, Puhl G, Kahl A, Berg T, et al. Peginterferon alfa-2b plus ribavirin for the treatment of hepatitis C recurrence following combined liver and kidney transplantation. Ann Transplant. 2007;12:22–27
  5. Saliba F, Lakehal M, Pageaux GP, Roche B, Vanlemmens C, Duvoux C, et al. Risk factors for new-onset diabetes mellitus after liver transplantation and impact of hepatitis C infection: an observational multicenter study. Liver Transpl. 2007;13:136–144
  6. Delgado-Borrho S, Liu YS, Jordan SH, Agrawal S, Zhang H, Christofi M, et al. Prospective study of liver transplant recipients with HCV infection: evidence for a causal relationship between HCV and insulin resistance. Liver Transpl. 2008;14:193–201
  7. Berenguer M, Royuela A, Zamora J. Immunosuppression with calcineurin inhibitors with respect to outcome of HCV recurrence after liver transplantation: results of a meta-analysis. Liver Transpl. 2007;13:21–29
  8. Vivarelli M, Burra P, La Barba G, Canova D, Senzolo M, Cucchetti A, et al. Influence of steroids on HCV recurrence after liver transplantation: a prospective study. J Hepatol. 2007;47:793–798
  9. Terrault NA, Shiffman ML, Lok ASF, Saab S, Tong L, Brown RS, et al. Outcomes in hepatitis C virus infected recipients of living donor vs. deceased donor liver transplantation. Liver Transpl. 2007;13:122–129
  10. Lecube A, Hernandez C, Genesca J, Esteban JI, Jardí R, Simó Rl. High prevalence of glucose abnormalities in patients with hepatitis C virus infection: a multivariate analysis considering the liver injury. Diabetes Care. 2004;27:1171–1175
  11. Negro F, Alaei M. Hepatitis C virus and type 2 diabetes. World J Gastroenterol. 2009;15:1537–1547
  12. del Pozo AC, Martín JD, Rodriguez-Laiz G, Sturdevant M, Iyer K, Schwartz M, et al. Outcome of combined liver and kidney transplantation in hepatitis C: a single-center long-term follow-up experience. Transplant Proc. 2009;41:1713–1716

☆ The author declared that he does not have anything to disclose regarding funding from industries or conflict of interest with respect to the manuscript.

PII: S0168-8278(09)00534-0

doi: 10.1016/j.jhep.2009.08.002

Journal of Hepatology
Volume 51, Issue 5 , Pages 839-841 , November 2009

Article Tools